Developmental Regulated Expression of Anti- and Pro-Apoptotic BCL-2 Family Genes During Human Early Embryonic Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|11|1361-1369

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.11, 2014-04, pp. : 1361-1369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Development of Pro-Apoptotic Cancer Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Anti-Apoptotic Bcl-2 Family Proteins by Natural Polyphenols New Avenues for Cancer Chemoprevention and Chemotherapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1387-1398

Bentham Science Publishers

Access to resources Recommend Favorite

In silico Methods for Designing Antagonists to Anti-apoptotic Members of Bcl-2 Family Proteins

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 11, 2012-09 ,pp. : 1144-1153

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Bromomelatonin Derivative Suppresses Apoptosis with Regulating the Expression of Bcl-2 Family Genes

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 10, 2011-12 ,pp. : 951-956

Bentham Science Publishers

Access to resources Recommend Favorite

Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity

By  

Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. : 1627-1639

Bentham Science Publishers

Access to resources Recommend Favorite